Academic Identity

Vidwan-ID : 139541

Edit Profile


  • Dr Vijaykumar G Warad

  • Professor
  • BLDE Deemed to be University
Publications 2014 - 2023

Publications

  • 32
    Journal Articles
  • 6
    Projects

Google Scholar

Co-author Network

Expertise

Medicine General and Internal

Professor, Department of General Medicine. Assistant Medical Superintendent 2016-2020.

Personal Information

Dr Vijaykumar G Warad

Male
General Medicine BLDE (Deemed to be University), Bangaramma Sajjan Campus
Vijayapura, Karnataka, India - 586103

Experience

  • Professor

    General Medicine

    BLDE Deemed to be University

  • Associate Professor

    General Medicine

    BLDE Deemed to be University

  • Assistant Professor

    General Medicine

    BLDE Deemed to be University

  • Lecturer

    General Medicine

    BLDE Deemed to be University

Qualification

  • MD

    Shri B M Patil Medical College Hospital and RC Bijapur

  • MBBS

    Shri B M Patil Medical College

Membership In Professional Bodies

2021

Innovative Physicians Forum

Life Member

2015

Geriatrics Society of India

Life Member

2009

API NATIONAL

LIFE

Read More
2021

Innovative Physicians Forum

Life Member

2015

Geriatrics Society of India

Life Member

2009

API NATIONAL

LIFE

2004

API State

Life time

2004

IMA State and National

Life time

Read Less

Membership In Committees

2022

Indian Medical Association Bijapur

EC

2019

Geriatrics Society of India

EC Member

2017

API Karnataka Chapter

EC Member

2022

Indian Medical Association Bijapur

EC

2019

Geriatrics Society of India

EC Member

2017

API Karnataka Chapter

EC Member

Read Less

Research Projects

Evaluation of safety and efficacy of hydroxychloroquine sulfate as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes patients uncontrolled on sulfonylurea + metformin combination.

Funding Agency : IPCA Laboratories Ltd., Mumbai

“AN OPEN LABEL , RANDOMIZED, MULTICENTRIC, ACTIVE-CONTROLLED PHASE-III TRIAL TO COMPARE THE EFFICACY, TOLERABILITY, AND SAFETY OF TABLET AZILSARTAN WITH TABLET OLMESARTAN IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GRADE 1 ESSENTIAL HYPERTENSION” PILOT STUDY

Funding Agency : SYNOKEM PHARMACEUTICALS LTD.SYNOKEM HOUSE,114/486, SUNDER VIHAR, OUTER RING ROAD, PASCHIM VIHAR, NEW DELHI-87

ELECTROCARDIOGRAPHIC CHANGES IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION (HIV)

Funding Agency : ICMR

Read More

Evaluation of safety and efficacy of hydroxychloroquine sulfate as an adjunct to diet and exercise to improve glycemic control in type 2 diabetes patients uncontrolled on sulfonylurea + metformin combination.

Funding Agency : IPCA Laboratories Ltd., Mumbai

“AN OPEN LABEL , RANDOMIZED, MULTICENTRIC, ACTIVE-CONTROLLED PHASE-III TRIAL TO COMPARE THE EFFICACY, TOLERABILITY, AND SAFETY OF TABLET AZILSARTAN WITH TABLET OLMESARTAN IN THE TREATMENT OF PATIENTS WITH NEWLY DIAGNOSED GRADE 1 ESSENTIAL HYPERTENSION” PILOT STUDY

Funding Agency : SYNOKEM PHARMACEUTICALS LTD.SYNOKEM HOUSE,114/486, SUNDER VIHAR, OUTER RING ROAD, PASCHIM VIHAR, NEW DELHI-87

ELECTROCARDIOGRAPHIC CHANGES IN PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION (HIV)

Funding Agency : ICMR

Prevalance of Preipheral Neuropathyi in Young Diabetic Patients

Funding Agency : BLDEDU

Diabetes Mellitus and Major Depression Disorder

Funding Agency : BLDEDU

ANAEMIA IN PATIENT WITH IMMUNODEFICIENCY VIRUS( HIV) INFECTION

Funding Agency : ICMR

Read Less

Publications (32)

Powered by